A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer ...

From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ...

Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...

Introduction Have you ever been concerned about a mole on your skin? While most moles are harmless, they can sometimes change ...

A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...

Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...

Rates of breast and thyroid cancer for women under 50 rose from 2002 to 2021, while men in the same age group had declining ...

Trial remains on track for completion and data readout in the second half of 2025COPENHAGEN, Denmark, January 15, 2025 - Evaxion Biotech A/S ...

TikTok and Instagram influencers have been peddling the “Barbie drug” to help you tan. It's a solution too good to be true.

Kimberly Werner Billet, MD, FAAD, is a board-certified dermatologist operating Dr. Kim Dermatology. She answers questions ...

Regeneron recently presented five-years results from the phase 3 EMPOWER-Lung 1 trial of Libtayo as a first-line treatment ...